BioAtla, Inc. (BCAB) — 分析师展望 / 分析师共识目标价为. 基于 9 位分析师评级, 共识为 看涨 — 6 买入, 3 持有.
分析师共识目标价为 $5.00, 上涨空间为 11% 相对于当前价格 $4.51.
分析师预估 每股收益(EPS)为 $-1.53 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.44 vs 预期 $-1.53 (超预期 +5.6%). 2025: 实际 $-1.01 vs 预期 $-1.08 (超预期 +6.5%). 分析师准确度: 94%.
BCAB 股票 — 12个月价格预测
$5.00
▲ +10.99% 上涨空间
平均目标价
Based on 9 Wall Street analysts offering 12-month price targets for BioAtla, Inc., the price target is $5.00.
平均目标价相对最新价格 $4.51 变动 +10.99%。
BCAB 分析师评级
Buy
基于过去3个月内 9 位分析师对 BioAtla, Inc. 的评级
EPS 预测 — BCAB
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.44
vs Est –$1.53
▲ 5.9% off
2025
Actual –$1.01
vs Est –$1.08
▲ 6.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — BCAB
78%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.011B
vs Est $0.011B
▼ 0.0% off
2025
Actual $0.002B
vs Est $0.003B
▼ 43.3% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
